We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Feasibility Study Supports Use of Immunomagnetic Approach to Study Circulating Cancer Cells

By LabMedica International staff writers
Posted on 01 Apr 2015
Print article
Image: In the immunomagnetic approach, circulating cancer cells are attracted by specific biomarkers to bind to an array of micromagnets for further analyses (Photo courtesy of Dartmouth College).
Image: In the immunomagnetic approach, circulating cancer cells are attracted by specific biomarkers to bind to an array of micromagnets for further analyses (Photo courtesy of Dartmouth College).
Cancer researchers have combined the strength of magnetic separation with the specificity of immunochemical biomarker recognition to demonstrate the feasibility of capturing and analyzing rare circulating cells from the blood stream of cancer patients.

Writing in the March 4, 2015, online edition of the journal Scientific Reports, investigators at Dartmouth College (NH, USA) described a two-dimensional micromagnet array that they used to characterize generation of the magnetic field and to quantify the impact of micromagnets on rare cell separation. In this paper, they presented a theoretical framework and technical approach to implement microscale magnetic immunoassay through modulating the local magnetic field towards enhanced capture and distribution of rare cancer cells.

"The concept is to use novel cell-machine interfaces, integrated sensing, actuation, and biomarker recognition functionalities to isolate these rare cells (one per billion hematologic cells) from whole blood to determine malignancy unambiguously," said senior author Dr. John X.J Zhang, professor of engineering at Dartmouth College. "We will base the quantitative assessment on multiple tumor markers. This project demonstrates that a relatively simple blood test may eventually be able to provide unambiguous information to doctors about particular cancers in individuals."

The investigators found that there was good agreement between their theory and results of experiments using a human colon cancer cell line (COLO205) as the capture targets.

Related Links:

Dartmouth College


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Unit-Dose Packaging solution
HLX
New
LH ELISA
Luteinizing Hormone ELISA
New
Urine Collection Container
Urine Monovette

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.